Home » Topics » BioWorld Science

BioWorld Science
RSS

Soluble RANKL inhibition may prevent tumor metastasis to bone

Sep. 5, 2019

Antimalarial kinase inhibitor identified at the University of Glasgow

Sep. 5, 2019

CRISPR targets fat cells, improves metabolism

Sep. 5, 2019

Evaluation of the effects of atractylenolide I in a new mouse model of cancer cachexia

Sep. 5, 2019

JMJD6 predicts poor prognosis in ovarian cancer and can be a new therapeutic target

Sep. 5, 2019

InnoCare Pharma identifies TRK inhibitors

Sep. 4, 2019

Beijing Scitech-Mq Pharmaceuticals describes RET and VEGFR2 inhibitors

Sep. 4, 2019

Jiangsu Aosaikang Pharmaceutical identifies H+/K+ ATPase inhibitors

Sep. 4, 2019

Phase II trial of AR-105 for ventilator-associated pneumonia does not meet primary endpoint

Sep. 4, 2019

Medshine Discovery divulges kynurenine production inhibitors

Sep. 4, 2019

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...